Literature DB >> 14672616

Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.

Lucia Wickert1, Muna Abiaka, Ursula Bolkenius, Axel M Gressner.   

Abstract

BACKGROUND/AIMS: Transforming growth factor (TGF)-beta receptors mediate TGF-beta signaling in activated hepatic stellate cells (HSC). This leads to pleiotropic cellular effects, e.g. to the production of extracellular matrix which is a hallmark for the development of liver fibrosis. Glucocorticoids and their receptors interact with the TGF-beta signaling pathway on the transcriptional and translational level.
METHODS: To characterize TGF-beta receptor expression during HSC transdifferentiation and to study the influence of corticosteroids on receptor transcription in several liver cells, we established a real-time polymerase chain reaction procedure for mRNA quantification with gene-specific standards.
RESULTS: All three TGF-beta receptor mRNAs are present in HSC and myofibroblasts. Whereas TGF beta receptor type I (T beta RI) shows a comparable mRNA expression during HSC transdifferentiation, T beta RII and T beta RIII mRNA concentration decreases in the course of time. In comparison with activated HSC T beta RIII mRNA is very low expressed in freshly isolated Kupffer cells and hepatocytes. Eight hours after corticosteroid treatment T beta RIII mRNA increased significantly in a time-and dose-dependent manner while the mRNA expression of T beta RI and T beta RII is not altered. The degree of induction of T beta RIII mRNA levels is also dependent upon the nature of the stimulating hormone: dexamethasone, hydrocortisone and aldosterone show different effects.
CONCLUSIONS: The increase of T beta RIII by corticosteroids indicates that these hormones are important regulators of this receptor and thereby they can modulate TGF-beta signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14672616     DOI: 10.1016/j.jhep.2003.09.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.

Authors:  Bernd Denecke; Lucia Wickert; Yan Liu; Loredana Ciuclan; Steven Dooley; Nadja M Meindl-Beinker
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.

Authors:  Yu-Sheng Li; Shu-Yuan Ni; Ying Meng; Xiao-Lan Shi; Xu-Wen Zhao; Hai-Hua Luo; Xu Li
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 3.  Roles for the type III TGF-beta receptor in human cancer.

Authors:  Catherine E Gatza; Sun Young Oh; Gerard C Blobe
Journal:  Cell Signal       Date:  2010-02-12       Impact factor: 4.315

4.  TGF-beta and mesenchymal hepatic involvement after visceral leishmaniasis.

Authors:  Maria Irma Seixas Duarte; Heitor Franco de Andrade; Cleusa Fumica Hirata Takamura; Antonio Sesso; Felipe Francisco Tuon
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

Review 5.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

6.  Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.

Authors:  Bo Gao; Xueming Zhang; Yongming Huang; Zhengpeng Yang; Yuguo Zhang; Weihui Zhang; Zu-Hua Gao; Dongbo Xue
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

7.  Complex fibroblast response to glucocorticoids may underlie variability of clinical efficacy in the vocal folds.

Authors:  Ryosuke Nakamura; Shigeyuki Mukudai; Renjie Bing; Michael J Garabedian; Ryan C Branski
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

8.  Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.

Authors:  Tamao Shinohara; Kevin Y Urayama; Atsushi Watanabe; Koshi Akahane; Kumiko Goi; Meixian Huang; Keiko Kagami; Masako Abe; Kanji Sugita; Yukinori Okada; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Takeshi Inukai
Journal:  J Cell Mol Med       Date:  2020-10-01       Impact factor: 5.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.